Chronic kidney disease at high altitude

Area of Science:

• Nephrology
• Altitude Medicine
• Environmental Health

Background:

• Chronic kidney disease (CKD) affects 10-11% of the population, with many living in or visiting high-altitude regions.
• Kidney oxygenation is already compromised in CKD patients, increasing vulnerability to hypoxia.
• The impact of high-altitude exposure on CKD progression and management remains largely unstudied.

Purpose of the Study:

• To review the effects of high altitude on CKD patients.
• To assess the risks of altitude exposure for individuals with pre-existing kidney disease.
• To discuss the management of altitude-related illnesses in CKD patients.

Main Methods:

• Literature review on high-altitude physiology and nephrology.
• Analysis of potential risks associated with hypoxemia in CKD.
• Examination of medication use for altitude illness prevention and treatment in CKD.

Main Results:

• Arterial hypoxemia at high altitude is postulated to accelerate CKD progression.
• CKD patients may be at increased risk for acute altitude illness.
• Guidelines for medication use in high-altitude environments for CKD patients are considered.

Conclusions:

• High-altitude exposure presents potential risks for CKD patients, including accelerated disease progression.
• Further research is needed to understand and mitigate these risks.
• Careful consideration of altitude exposure and appropriate medical management are crucial for CKD patients in mountainous regions.